Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 347, Issue 1-2, Pages 149-155Publisher
ELSEVIER
DOI: 10.1016/j.ijpharm.2007.06.039
Keywords
insulin; microsphere; oral delivery; polyanhydride
Categories
Ask authors/readers for more resources
The bioadhesive polymer, poly(fumaric-co-sebacic) anhydride, p(FASA), was used to fabricate small diameter insulin microspheres and evaluate their in vivo performance in a type I diabetic rat as well as a type I diabetic dog model. The process of phase inversion nanoencapsulation was used to fabricate p(FASA) microspheres containing insulin. Using laser diffraction spectrometry, 90% of the microspheres used in the fed double dose rat experiments were found to have a volumetric diameter of 5.9 mu m or smaller. In comparison, 90% of the microspheres used in fed single dose rat experiments were found to have a volumetric diameter of 2.6 mu m or smaller while the microspheres used in the diabetic dog experiments were found to have a volumetric diameter of 1.2 mu m or smaller. Insulin microspheres administered to diabetic rats in the fed double dose experiment produced a relative bioavailability (RB) of 23.3% while insulin microspheres administered to diabetic rats in the fed single dose experiment produced a RB of 5.5 +/- 1.7%. Insulin microspheres administered to fasted diabetic dogs produced a RB of 5.5 +/- 3.4%. (C) 2007 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available